Phentermine, an FDA-approved appetite suppressant since 1959, works through central nervous system stimulation, while tirzepatide (Zepbound, Mounjaro), approved in 2023 for obesity, operates through dual GIP/GLP-1 receptor pathways
from 7 to 7.5 min, Phase B was further decreased to 50%
Highlights Older adults supplementing with the glutathione antioxidant precursor combination GlyNAC reduces cellular stress
The medications are protected by patents, and generic formulations are not expected in the near future
Theranostics 12:35343552 Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, Shi JX, Huang W, Wang YP, Jiang YZ et al (2023) Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
Increasing libido and improving sexual function